Ryan Specialty Group Stock Hits All-Time High at $75.87

Published 29/11/2024, 17:02
Ryan Specialty Group Stock Hits All-Time High at $75.87

In a remarkable display of market confidence, Ryan Specialty Group Holdings Inc. (RYAN) stock soared to an all-time high, reaching a price level of $75.87. The company, now valued at nearly $20 billion, maintains a "GREAT" financial health score according to InvestingPro analysis. This peak comes amidst a year of significant growth for the company, with the stock witnessing an impressive 1-year change of 65.96%. Trading at a P/E ratio of 88, the stock appears to be fully valued based on InvestingPro's Fair Value assessment. Investors have shown increasing enthusiasm for RYAN's business model and growth prospects, propelling the stock to new heights and setting a robust benchmark for its future performance. For deeper insights into RYAN's valuation and growth potential, access the comprehensive Pro Research Report, available exclusively with an InvestingPro subscription.

In other recent news, Ryan Specialty Holdings reported a significant increase in its third-quarter revenue and earnings, with a 20.5% rise in total revenue to $605 million. The firm's organic growth accounted for 11.8% of this increase. Adjusted earnings before interest, taxes, depreciation, amortization, and changes in acquisition costs (EBITDAC) grew by 29.4% to $190 million, while adjusted diluted earnings per share (EPS) rose by 28% to $0.41. These developments reinforce the company's strategic acquisitions and commitment to organic growth.

Recent acquisitions, such as US Assure and Innovisk, played a significant role in the company's robust performance. In addition, Ryan Specialty aims to maintain an organic revenue growth guidance of 13.0% to 14.0% for 2024. Despite facing rate declines in the property market, the company managed to gain market share in the sector.

Looking ahead, analysts anticipate that positive dynamics in casualty markets, particularly in high-hazard verticals, will drive growth. The company's ACCELERATE 2025 program is also on track to achieve $60 million in annual savings by 2025. These are recent developments that continue to shape Ryan Specialty's trajectory in the specialty insurance sector.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.